ISB News

ISB’s 100K Project A Top Story on GenomeWeb

By ISBUSA

Infographic showing types of data

GenomeWeb announces 2014’s top-10 most-read articles on personalized medicine and the article on ISB’s 100K Wellness Project was No. 1. Here’s an excerpt from GenomeWeb’s Jan. 5 story:

NEW YORK (GenomeWeb) – GenomeWeb readers in 2014 were most interested in a story about a large study investigating why some people remain healthy while others get sick. The top article was about healthcare entrepreneur Leroy Hood’s efforts to advance a “wellness industry” by studying the factors that contribute to people staying healthy. In the study, researchers hope to enroll 100,000 patients in good health, collect data on them over two decades via genomic and other complex tests, assess their nutrition, analyze their microbiome, and perform organ-specific checkups. The aim is to gain a better understanding of the myriad factors contributing to the development of diseases, and develop tools and strategies to predict who will become sick so doctors can intervene early. Read more (requires free registration)…

Learn more about the 100K Wellness Project.

Recent Articles

  • ISB Associate Professor Dr. Sean Gibbons

    ‘1 in 1,000:’ Dr. Sean Gibbons Named Highly Cited Researcher for 2023

    ISB Associate Professor Dr. Sean Gibbons was named a Highly Cited Researcher for 2023. It is the second consecutive year Gibbons has earned the distinction. The Highly Cited Research list is generated annually by Clarivate, which says: “Of the world’s population of scientists and social scientists, Highly Cited Researchers are 1 in 1,000.”

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on.

  • Breakthrough T Cell Discovery Has Huge Potential for Engineering Custom Immune Responses

    In a breakthrough discovery that changes how we understand T cells and with implications of how we can better engineer custom immune responses to fight disease, Institute for Systems Biology researchers showed that the different disease-fighting functions of different T cells are determined by the genetically encoded T-cell receptor sequence that are unique to those cells.